Stocks and Investing
Stocks and Investing
Wed, November 15, 2023
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
[ Wed, Nov 15th 2023
] - WOPRAI
Bill Sutherland Maintained (AGL) at Strong Buy with Decreased Target to $22 on, Nov 15th, 2023
Bill Sutherland of Benchmark, Maintained "agilon health, inc." (AGL) at Strong Buy with Decreased Target from $28 to $22 on, Nov 15th, 2023.
Bill has made no other calls on AGL in the last 4 months.
There are 5 other peers that have a rating on AGL. Out of the 5 peers that are also analyzing AGL, 0 agree with Bill's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Bill
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $16 on, Monday, November 13th, 2023
- Jailendra Singh of "Truist Securities" Maintained at Strong Buy with Decreased Target to $23 on, Thursday, November 9th, 2023
- Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $22 on, Thursday, November 9th, 2023
- Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $23 on, Friday, November 3rd, 2023
- Gary Taylor of "TD Cowen" Maintained at Buy with Decreased Target to $25 on, Tuesday, August 15th, 2023
Contributing Sources